Malcolm Stoker

1.3k total citations
18 papers, 966 citations indexed

About

Malcolm Stoker is a scholar working on Physiology, Neurology and Pharmacology. According to data from OpenAlex, Malcolm Stoker has authored 18 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 11 papers in Neurology and 4 papers in Pharmacology. Recurrent topics in Malcolm Stoker's work include Pain Mechanisms and Treatments (13 papers), Botulinum Toxin and Related Neurological Disorders (11 papers) and Cancer Treatment and Pharmacology (4 papers). Malcolm Stoker is often cited by papers focused on Pain Mechanisms and Treatments (13 papers), Botulinum Toxin and Related Neurological Disorders (11 papers) and Cancer Treatment and Pharmacology (4 papers). Malcolm Stoker collaborates with scholars based in Netherlands, United Kingdom and United States. Malcolm Stoker's co-authors include Stephen Long, Floortje van Nooten, Nathaniel P. Katz, Mark Versavel, Hilary A. Feister, James P. Young, Robert van Seventer, Cathelijne Alleman, Barry Turnbull and Jeremiah Trudeau and has published in prestigious journals such as Pain, Neuropharmacology and Journal of Pain.

In The Last Decade

Malcolm Stoker

17 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malcolm Stoker Netherlands 14 690 406 204 109 106 18 966
Pallai Shillo United Kingdom 14 827 1.2× 538 1.3× 136 0.7× 109 1.0× 22 0.2× 21 1.1k
Lizu Xiao China 18 428 0.6× 219 0.5× 156 0.8× 64 0.6× 72 0.7× 48 900
M. Backonja United States 8 325 0.5× 139 0.3× 198 1.0× 86 0.8× 27 0.3× 21 506
Gordon Sloan United Kingdom 13 609 0.9× 366 0.9× 87 0.4× 48 0.4× 20 0.2× 22 930
David J. Kopsky Netherlands 15 321 0.5× 151 0.4× 122 0.6× 40 0.4× 9 0.1× 44 574
M. ALEXANDER OTTO Denmark 6 541 0.8× 252 0.6× 204 1.0× 108 1.0× 6 0.1× 9 750
Maria Osikowicz Poland 13 833 1.2× 133 0.3× 163 0.8× 42 0.4× 35 0.3× 14 1.1k
Kay H. Steen Germany 14 540 0.8× 40 0.1× 82 0.4× 57 0.5× 327 3.1× 17 1.2k
Dong Eon Moon South Korea 16 374 0.5× 165 0.4× 187 0.9× 35 0.3× 14 0.1× 55 750
May Hamza Egypt 16 427 0.6× 85 0.2× 366 1.8× 56 0.5× 21 0.2× 30 939

Countries citing papers authored by Malcolm Stoker

Since Specialization
Citations

This map shows the geographic impact of Malcolm Stoker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm Stoker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm Stoker more than expected).

Fields of papers citing papers by Malcolm Stoker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malcolm Stoker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm Stoker. The network helps show where Malcolm Stoker may publish in the future.

Co-authorship network of co-authors of Malcolm Stoker

This figure shows the co-authorship network connecting the top 25 collaborators of Malcolm Stoker. A scholar is included among the top collaborators of Malcolm Stoker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malcolm Stoker. Malcolm Stoker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nooten, Floortje van, M. Treur, Krystallia Pantiri, Malcolm Stoker, & M. Charokopou. (2017). Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis. Clinical Therapeutics. 39(4). 787–803.e18. 80 indexed citations
2.
Simpson, David M., Jessica Robinson‐Papp, Joanna Van, et al.. (2016). Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study. Journal of Pain. 18(1). 42–53. 103 indexed citations
3.
Vinik, Aaron I., Serge Perrot, Etta J. Vinik, et al.. (2016). Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study. BMC Neurology. 16(1). 251–251. 69 indexed citations
4.
Gálvez, Rafael, Graeme Moyle, Christian Maihöfner, et al.. (2016). Capsaicin 8% Patch Repeat Treatment in Nondiabetic Peripheral Neuropathic Pain. Clinical Journal of Pain. 33(10). 921–931. 36 indexed citations
5.
Alleman, Cathelijne, et al.. (2015). Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: A review of the literature. Diabetes Research and Clinical Practice. 109(2). 215–225. 161 indexed citations
6.
7.
Katz, Nathaniel P., et al.. (2014). Predictors of Response in Patients With Postherpetic Neuralgia and HIV-Associated Neuropathy Treated With the 8% Capsaicin Patch (Qutenza). Clinical Journal of Pain. 31(10). 859–866. 20 indexed citations
8.
Wiklund, Ingela, Stefan Holmström, Malcolm Stoker, Kathleen W. Wyrwich, & Mary Ann Devine. (2013). Are treatment benefits in neuropathic pain reflected in the self assessment of treatment questionnaire?. Health and Quality of Life Outcomes. 11(1). 8–8. 9 indexed citations
9.
Paillard, Florence, et al.. (2013). Qutenza (Capsaicin) 8% Patch Onset and Duration of Response and Effects of Multiple Treatments in Neuropathic Pain Patients. Clinical Journal of Pain. 30(4). 286–294. 41 indexed citations
10.
Paillard, Florence, et al.. (2013). Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: A meta-analysis of the Qutenza Clinical Trials Database. Pain. 154(9). 1632–1639. 68 indexed citations
11.
Martini, Chris H., Ashraf Yassen, Axel Krebs‐Brown, et al.. (2013). A novel approach to identify responder subgroups and predictors of response to low‐ and high‐dose capsaicin patches in postherpetic neuralgia. European Journal of Pain. 17(10). 1491–1501. 42 indexed citations
12.
Wyrwich, Kathleen W., Ariane K. Kawata, Christine Thompson, et al.. (2012). Validation of the Self-Assessment of Treatment Questionnaire among Patients with Postherpetic Neuralgia. Pain Research and Treatment. 2012. 1–15. 10 indexed citations
13.
Arnold, Lesley M., Krai Chatamra, Ian Hirsch, & Malcolm Stoker. (2010). Safety and efficacy of esreboxetine in patients with fibromyalgia: An 8-week, multicenter, randomized, double-blind, placebo-controlled study. Clinical Therapeutics. 32(9). 1618–1632. 24 indexed citations
14.
Seventer, Robert van, et al.. (2006). Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13‐week, randomized trial. Current Medical Research and Opinion. 22(2). 375–384. 202 indexed citations
15.
Goodacre, Tim, et al.. (1988). Split skin grafting using topical local anaesthesia (EMLA): a comparison with infiltrated anaesthesia. British Journal of Plastic Surgery. 41(5). 533–538. 53 indexed citations
16.
Bradshaw, C. M., Malcolm Stoker, & E. Szabadi. (1983). Comparison of the neuronal responses to 5-hydroxytryptamine, noradrenaline and phenylephrine in the cerebral cortex: Effects of haloperidol and methysergide. Neuropharmacology. 22(6). 677–685. 22 indexed citations
17.
Bradshaw, C. M., Raymund Y.K. Pun, N. Traverse Slater, Malcolm Stoker, & E. Szabadi. (1983). Differential antagonistic effects of haloperidol on excitatory responses of cortical neurones to phenylephrine, noradrenaline and dopamine. Neuropharmacology. 22(8). 945–952. 8 indexed citations
18.
Bradshaw, C. M., Malcolm Stoker, & E. Szabadi. (1982). The effect of microelectrophoretically applied clonidine on single cerebral cortical neurones in the rat. Naunyn-Schmiedeberg s Archives of Pharmacology. 320(3). 230–234. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pallai Shillo Breakdown of academic impact, for papers by Lizu Xiao Breakdown of academic impact, for papers by M. Backonja Breakdown of academic impact, for papers by Gordon Sloan Breakdown of academic impact, for papers by David J. Kopsky Breakdown of academic impact, for papers by M. ALEXANDER OTTO Breakdown of academic impact, for papers by Maria Osikowicz Breakdown of academic impact, for papers by Kay H. Steen Breakdown of academic impact, for papers by Dong Eon Moon Breakdown of academic impact, for papers by May Hamza
Rankless by CCL
2026